全文获取类型
收费全文 | 5730篇 |
免费 | 472篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 215篇 |
妇产科学 | 206篇 |
基础医学 | 785篇 |
口腔科学 | 61篇 |
临床医学 | 560篇 |
内科学 | 1142篇 |
皮肤病学 | 68篇 |
神经病学 | 695篇 |
特种医学 | 98篇 |
外科学 | 512篇 |
综合类 | 63篇 |
一般理论 | 9篇 |
预防医学 | 817篇 |
眼科学 | 146篇 |
药学 | 346篇 |
中国医学 | 6篇 |
肿瘤学 | 427篇 |
出版年
2024年 | 21篇 |
2023年 | 172篇 |
2022年 | 248篇 |
2021年 | 503篇 |
2020年 | 274篇 |
2019年 | 335篇 |
2018年 | 311篇 |
2017年 | 217篇 |
2016年 | 229篇 |
2015年 | 243篇 |
2014年 | 284篇 |
2013年 | 332篇 |
2012年 | 476篇 |
2011年 | 389篇 |
2010年 | 199篇 |
2009年 | 153篇 |
2008年 | 254篇 |
2007年 | 291篇 |
2006年 | 229篇 |
2005年 | 202篇 |
2004年 | 171篇 |
2003年 | 136篇 |
2002年 | 114篇 |
2001年 | 29篇 |
2000年 | 19篇 |
1999年 | 31篇 |
1998年 | 25篇 |
1997年 | 19篇 |
1996年 | 20篇 |
1995年 | 15篇 |
1994年 | 9篇 |
1993年 | 7篇 |
1992年 | 14篇 |
1991年 | 23篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 17篇 |
1987年 | 20篇 |
1986年 | 9篇 |
1985年 | 16篇 |
1984年 | 7篇 |
1982年 | 8篇 |
1980年 | 9篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1974年 | 7篇 |
1972年 | 7篇 |
1969年 | 6篇 |
1968年 | 7篇 |
排序方式: 共有6210条查询结果,搜索用时 15 毫秒
941.
942.
Hannah Louise Brooke Mats Talbäck Jesper Hörnblad Lars Age Johansson Jonas Filip Ludvigsson Maria Feychting Rickard Ljung 《European journal of epidemiology》2017,32(9):765-773
Sweden has a long tradition of recording cause of death data. The Swedish cause of death register is a high quality virtually complete register of all deaths in Sweden since 1952. Although originally created for official statistics, it is a highly important data source for medical research since it can be linked to many other national registers, which contain data on social and health factors in the Swedish population. For the appropriate use of this register, it is fundamental to understand its origins and composition. In this paper we describe the origins and composition of the Swedish cause of death register, set out the key strengths and weaknesses of the register, and present the main causes of death across age groups and over time in Sweden. This paper provides a guide and reference to individuals and organisations interested in data from the Swedish cause of death register. 相似文献
943.
944.
945.
Cristian Ricci Janet Carboo Hannah Asare Cornelius M. Smuts Robin Dolman Martani Lombard 《Maternal & child nutrition》2019,15(2)
Child mortality is a major public health problem in sub‐Saharan Africa and is influenced by nutritional status. A conceptual framework was proposed to explain factors related to undernutrition. Previously proposed conceptual frameworks for undernutrition do not consider child mortality and describe factors related to undernutrition from a qualitative viewpoint only. A structural equation modelling approach was applied to the data from World Bank and FAO databases collected from over 37 sub‐Saharan countries from 2000 to the most recent update. Ten food groups, exclusive breastfeeding, poverty and illiteracy rates, and environmental hygiene were investigated in relation to underweight, stunting, low birthweight, and child mortality. Standardized beta coefficient was reported, and graphical models were used to depict the relations among factors related to under‐five mortality in sub‐Saharan Africa. Child mortality in sub‐Saharan Africa ranged between 76 and 127 × 1,000. In the same period, low birthweight rate was about 14%. Poverty and illiteracy are confirmed to affect health resources, which in turn influenced nutritional status and child mortality. Among nutritional factors, exclusive breastfeeding had a greater influence than food availability. Low birthweight, more than underweight and stunting, influenced child mortality. Structural equation modelling is a suitable way to disentangle the complex quantitative framework among factors determining child mortality in sub‐Saharan Africa. Acting on poverty at the base appear to be the more effective strategy along with improvement of breastfeeding practice and improvement of hygiene conditions. 相似文献
946.
947.
Transition to adult care for pediatric liver transplant recipients: the Western Australian experience 下载免费PDF全文
Tim Mitchell Hannah Gooding Cathy Mews Leon Adams Gerry MacQuillan George Garas Madhur Ravikumara Ainslie Lopez Megan Collins Gary Jeffrey 《Pediatric transplantation》2017,21(1)
Transition to adult care is a vulnerable period for pediatric transplant recipients and is associated with reduced medication compliance, graft loss, and increased mortality. Psychosocial outcomes in young adults differ between pediatric transplant recipients and their healthy peers. We conducted a single‐center, retrospective cohort study of all pediatric liver transplant recipients who were transitioned through our center. This study aimed to assess the outcomes of transitioned pediatric liver transplant recipients at an Australian center, including mortality, adherence, and psychosocial morbidity. The 1‐ and 5‐year survival rates following transition were 100% and 92%, respectively. There were no episodes of late rejection. In total, 66.7% of patients were compliant with immunosuppression and 61.1% of patients were compliant with clinic attendance. There was a significant relationship between medication compliance and clinic attendance, as well as presence of psychological issues with clinic non‐attendance. Psychosocial outcomes were in keeping with age‐matched data from the general population. All patients were employed or studying following transition. This is the first study of its kind in the Australian population, and outcomes were superior to published international data. Despite the demonstrated good outcomes, transition programs may improve healthcare engagement in this cohort. 相似文献
948.
Herman Avner Cohen Moshe Hoshen Shmuel Gur Arie Bahir Yoseph Laks Hannah Blau 《World journal of pediatrics : WJP》2017,13(1):27-33
Background
Available pediatric treatments for acute cough are limited by lack of demonstrated efficacy. The objective of this trial is to compare the effects of a polysaccharide-resin-honey based cough syrup, and carbocysteine syrups on nocturnal and daytime cough associated with childhood upper respiratory tract infections (URIs).Methods
Using a single-blind randomization design, the study recruited children from 4 general pediatric community clinics. Participants included 150 children aged 2 to 5 years with an URI, nocturnal and daytime cough and illness duration of ≤7 days. To be eligible, children had to be free of medication on the day before presentation. A survey was administered to parents on 4 consecutive days beginning from the day of presentation in clinic. Children received the study preparation on the first evening and then 3 times per day for 3 further days. Main outcome measures were cough frequency, cough severity, bothersome nature of cough, and quality of sleep for both child and parent.Results
Both preparations were well tolerated and cough improved over the study period. After one night and on all survey days, there was a significantly better result for polysaccharide-resin-honey (P<0.05) for all the main outcome measures. The trend of improvement over the 4 days was steeper for polysaccharide-resin-honey (P<0.05) with regards to all cough parameters.Conclusions
Both polysaccharide-resin-honey and carbocysteine cough syrups were well tolerated in children over 2 years of age. The polysaccharide-resin-honey syrup was associated with a more rapid and greater improvement in all clinical cough symptoms measured, beginning from the first night of therapy. Both nocturnal and daytime cough improved, as did sleep quality for both children and parents.949.
950.
Alpesh Amin Allison Keshishian Jeffrey Trocio Oluwaseyi Dina Hannah Le Lisa Rosenblatt 《Current medical research and opinion》2017,33(9):1595-1604
Objective: To compare the risk and cost of stroke/systemic embolism (SE) and major bleeding between each direct oral anticoagulant (DOAC) and warfarin among non-valvular atrial fibrillation (NVAF) patients.Methods: Patients (≥65 years) initiating warfarin or DOACs (apixaban, rivaroxaban, and dabigatran) were selected from the Medicare database from 1 January 2013 to 31 December 2014. Patients initiating each DOAC were matched 1:1 to warfarin patients using propensity score matching to balance demographics and clinical characteristics. Cox proportional hazards models were used to estimate the risks of stroke/SE and major bleeding of each DOAC vs. warfarin. Two-part models were used to compare the stroke/SE- and major-bleeding-related medical costs between matched cohorts.Results: Of the 186,132 eligible patients, 20,803 apixaban–warfarin pairs, 52,476 rivaroxaban–warfarin pairs, and 16,731 dabigatran–warfarin pairs were matched. Apixaban (hazard ratio [HR]?=?0.40; 95% confidence interval [CI] 0.31, 0.53) and rivaroxaban (HR?=?0.72; 95% CI 0.63, 0.83) were significantly associated with lower risk of stroke/SE compared to warfarin. Apixaban (HR?=?0.51; 95% CI 0.44, 0.58) and dabigatran (HR?=?0.79; 95% CI 0.69, 0.91) were significantly associated with lower risk of major bleeding; rivaroxaban (HR?=?1.17; 95% CI 1.10, 1.26) was significantly associated with higher risk of major bleeding compared to warfarin. Compared to warfarin, apixaban ($63 vs. $131) and rivaroxaban ($93 vs. $139) had significantly lower stroke/SE-related medical costs; apixaban ($292 vs. $529) and dabigatran ($369 vs. $450) had significantly lower major bleeding-related medical costs.Conclusions: Among the DOACs in the study, only apixaban is associated with a significantly lower risk of stroke/SE and major bleeding and lower related medical costs compared to warfarin. 相似文献